🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 18 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 24/07/2001 | 36,68 | 37,32 | 36,16 | 36,72 | +0,00% | 3,16% | 55.517 |
| 23/07/2001 | 38,18 | 38,55 | 36,68 | 36,72 | -4,76% | 4,90% | 25.969 |
| 20/07/2001 | 37,62 | 38,59 | 37,24 | 38,55 | +2,90% | 3,58% | 19.396 |
| 19/07/2001 | 37,13 | 38,14 | 37,13 | 37,47 | +0,91% | 2,72% | 13.572 |
| 18/07/2001 | 37,95 | 38,74 | 36,79 | 37,13 | -3,60% | 5,13% | 25.888 |
| 17/07/2001 | 36,72 | 39,41 | 36,72 | 38,52 | +6,08% | 7,34% | 56.907 |
| 16/07/2001 | 37,62 | 37,62 | 36,12 | 36,31 | -0,31% | 3,98% | 23.698 |
| 13/07/2001 | 37,43 | 37,62 | 36,42 | 36,42 | -1,42% | 3,20% | 38.445 |
| 12/07/2001 | 37,06 | 37,43 | 36,72 | 36,94 | +1,23% | 1,92% | 72.643 |
| 11/07/2001 | 35,22 | 37,06 | 35,22 | 36,49 | +0,41% | 5,21% | 100.428 |
| 10/07/2001 | 39,30 | 39,30 | 36,12 | 36,34 | -4,71% | 8,10% | 76.303 |
| 09/07/2001 | 39,30 | 39,83 | 38,14 | 38,14 | -4,59% | 4,29% | 224.660 |
| 06/07/2001 | 42,11 | 42,11 | 39,79 | 39,98 | -5,49% | 5,51% | 65.670 |
| 05/07/2001 | 42,26 | 43,01 | 42,18 | 42,30 | -0,53% | 1,95% | 33.984 |
| 03/07/2001 | 43,23 | 43,23 | 42,26 | 42,52 | -0,70% | 2,25% | 42.239 |
| 02/07/2001 | 43,31 | 43,98 | 42,30 | 42,82 | +1,24% | 3,89% | 52.979 |
| 29/06/2001 | 43,83 | 45,36 | 42,30 | 42,30 | -3,58% | 7,00% | 66.658 |
| 28/06/2001 | 42,26 | 44,88 | 42,11 | 43,87 | +1,03% | 6,55% | 43.735 |
| 27/06/2001 | 41,92 | 43,98 | 41,88 | 43,42 | -2,44% | 5,00% | 29.682 |
| 26/06/2001 | 41,73 | 44,84 | 41,55 | 44,50 | +6,16% | 7,89% | 47.956 |
| 25/06/2001 | 43,64 | 43,79 | 41,62 | 41,92 | -4,84% | 4,97% | 55.784 |
| 22/06/2001 | 45,70 | 46,53 | 44,02 | 44,05 | -4,46% | 5,49% | 33.529 |
| 21/06/2001 | 45,78 | 46,30 | 44,47 | 46,11 | -0,08% | 4,01% | 22.602 |
| 20/06/2001 | 43,34 | 46,15 | 43,04 | 46,15 | +7,22% | 7,17% | 39.060 |
| 19/06/2001 | 44,05 | 45,40 | 43,04 | 43,04 | -0,95% | 5,35% | 22.869 |
| 18/06/2001 | 45,07 | 46,79 | 43,38 | 43,46 | -7,12% | 7,56% | 24.927 |
| 15/06/2001 | 47,16 | 47,65 | 46,79 | 46,79 | +2,04% | 1,83% | 38.499 |
| 14/06/2001 | 46,34 | 47,80 | 45,48 | 45,85 | -1,13% | 5,01% | 31.980 |
| 13/06/2001 | 49,22 | 49,74 | 46,38 | 46,38 | -4,69% | 6,84% | 44.296 |
| 12/06/2001 | 45,29 | 49,03 | 44,92 | 48,66 | +8,33% | 9,09% | 55.197 |